Literature DB >> 19381799

Chronic exposure to high levels of zinc or copper has little effect on brain metal homeostasis or Abeta accumulation in transgenic APP-C100 mice.

Christa J Maynard1, Roberto Cappai, Irene Volitakis, Katrina M Laughton, Colin L Masters, Ashley I Bush, Qiao-Xin Li.   

Abstract

Aberrant metal homeostasis may enhance the formation of reactive oxygen species and Abeta oligomerization and may therefore be a contributing factor in Alzheimer's disease. This study investigated the effect of chronic high intake of dietary Zn or Cu on brain metal levels and the accumulation and solubility of Abeta in vivo, using a transgenic mouse model that over expresses the C-terminal containing Abeta fragment of human amyloid precursor protein but does not develop amyloid deposits. Exposure to chronic high Zn or Cu in the drinking water resulted in only slight elevations of the respective metals in the brain. Total Abeta levels were unchanged although soluble Abeta levels were slightly decreased, without visible plaque formation, enhanced gliosis, antioxidant upregulation or neuronal loss. This study indicates that brain metal levels are only marginally altered by long term oral exposure to extremely high Cu or Zn levels, and that this does not induce Abeta-amyloid formation in human Abeta expressing, amyloid-free mice, although this is sufficient to modulate Abeta solubility in vivo.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19381799     DOI: 10.1007/s10571-009-9401-7

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  51 in total

1.  Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome.

Authors:  A Nunomura; G Perry; K Hirai; G Aliev; A Takeda; S Chiba; M A Smith
Journal:  Ann N Y Acad Sci       Date:  1999       Impact factor: 5.691

2.  Degradation of the Alzheimer disease amyloid beta-peptide by metal-dependent up-regulation of metalloprotease activity.

Authors:  Anthony R White; Tai Du; Katrina M Laughton; Irene Volitakis; Robyn A Sharples; Michel E Xilinas; David E Hoke; R M Damian Holsinger; Geneviève Evin; Robert A Cherny; Andrew F Hill; Kevin J Barnham; Qiao-Xin Li; Ashley I Bush; Colin L Masters
Journal:  J Biol Chem       Date:  2006-04-28       Impact factor: 5.157

3.  4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.

Authors:  L M Sayre; D A Zelasko; P L Harris; G Perry; R G Salomon; M A Smith
Journal:  J Neurochem       Date:  1997-05       Impact factor: 5.372

4.  Trace copper levels in the drinking water, but not zinc or aluminum influence CNS Alzheimer-like pathology.

Authors:  D L Sparks; R Friedland; S Petanceska; B G Schreurs; J Shi; G Perry; M A Smith; A Sharma; S Derosa; C Ziolkowski; G Stankovic
Journal:  J Nutr Health Aging       Date:  2006 Jul-Aug       Impact factor: 4.075

5.  Zinc administration restores the impaired immune response observed in mice receiving excess copper by oral route.

Authors:  M Pocino; I Malavé; L Baute
Journal:  Immunopharmacol Immunotoxicol       Date:  1990       Impact factor: 2.730

6.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

Authors:  T Miura; K Suzuki; N Kohata; H Takeuchi
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

Review 7.  Metals and amyloid-beta in Alzheimer's disease.

Authors:  Christa J Maynard; Ashley I Bush; Colin L Masters; Roberto Cappai; Qiao-Xin Li
Journal:  Int J Exp Pathol       Date:  2005-06       Impact factor: 1.925

8.  APP intracellular domain is increased and soluble Abeta is reduced with diet-induced hypercholesterolemia in a transgenic mouse model of Alzheimer disease.

Authors:  Amee J George; R M Damian Holsinger; Catriona A McLean; Katrina M Laughton; Konrad Beyreuther; Genevieve Evin; Colin L Masters; Qiao-Xin Li
Journal:  Neurobiol Dis       Date:  2004-06       Impact factor: 5.996

9.  Aggregation and metal-binding properties of mutant forms of the amyloid A beta peptide of Alzheimer's disease.

Authors:  A Clements; D Allsop; D M Walsh; C H Williams
Journal:  J Neurochem       Date:  1996-02       Impact factor: 5.372

Review 10.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

View more
  7 in total

1.  Neuroprotective effects of some seaweeds against Zn - induced neuronal damage in HT-22 cells via modulation of redox imbalance, inhibition of apoptosis and acetylcholinesterase activity.

Authors:  Tosin A Olasehinde; Ademola O Olaniran; Anthony I Okoh
Journal:  Metab Brain Dis       Date:  2019-07-26       Impact factor: 3.584

2.  Dietary zinc supplementation of 3xTg-AD mice increases BDNF levels and prevents cognitive deficits as well as mitochondrial dysfunction.

Authors:  C Corona; F Masciopinto; E Silvestri; A Del Viscovo; R Lattanzio; R La Sorda; D Ciavardelli; F Goglia; M Piantelli; L M T Canzoniero; S L Sensi
Journal:  Cell Death Dis       Date:  2010-10-28       Impact factor: 8.469

Review 3.  Zinc and its effects on oxidative stress in Alzheimer's disease.

Authors:  Ye Yuan; Fenglan Niu; Ya Liu; Na Lu
Journal:  Neurol Sci       Date:  2014-02-13       Impact factor: 3.307

4.  Gene-environment interaction research and transgenic mouse models of Alzheimer's disease.

Authors:  L Chouliaras; A S R Sierksma; G Kenis; J Prickaerts; M A M Lemmens; I Brasnjevic; E L van Donkelaar; P Martinez-Martinez; M Losen; M H De Baets; N Kholod; F van Leeuwen; P R Hof; J van Os; H W M Steinbusch; D L A van den Hove; B P F Rutten
Journal:  Int J Alzheimers Dis       Date:  2010-10-05

5.  Zinc overload enhances APP cleavage and Aβ deposition in the Alzheimer mouse brain.

Authors:  Chun-Yan Wang; Tao Wang; Wei Zheng; Bao-Lu Zhao; Gorm Danscher; Yu-Hua Chen; Zhan-You Wang
Journal:  PLoS One       Date:  2010-12-17       Impact factor: 3.240

6.  High dose zinc supplementation induces hippocampal zinc deficiency and memory impairment with inhibition of BDNF signaling.

Authors:  Yang Yang; Xiao-Peng Jing; Shou-Peng Zhang; Run-Xia Gu; Fang-Xu Tang; Xiu-Lian Wang; Yan Xiong; Mei Qiu; Xu-Ying Sun; Dan Ke; Jian-Zhi Wang; Rong Liu
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240

Review 7.  The essential elements of Alzheimer's disease.

Authors:  Peng Lei; Scott Ayton; Ashley I Bush
Journal:  J Biol Chem       Date:  2020-11-27       Impact factor: 5.157

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.